A retrospective cross-sectional analysis of global esophageal cancer and gastroesophageal reflux disease burden: temporal trends, regional disparities, and epidemiologic associations
Abstract
MATERIALS AND METHODS
We analyzed data from 204 countries and territories (1990-2021) using the Global Burden of Disease (GBD) 2021 study. Incidence and disability-adjusted life years (DALYs) for EC and GERD were assessed by age, sex, and region. Time-series modeling, hierarchical clustering, and time-lagged analysis were employed to explore epidemiological trends and potential associations.
RESULTS
In 2021, EC caused 576,529 new cases and 12.99 million DALYs globally, with an age-standardized DALY rate of 148.6 per 100,000. GERD accounted for 324.1 million new cases and 6.34 million DALYs, corresponding to a rate of 75.6 per 100,000. East Asia had the highest EC burden, while GERD burden peaked in Tropical Latin America. From 1990 to 2021, EC burden declined, while GERD increased slightly. EC burden remained high in men and in high-middle socio-demographic index (SDI) regions. GERD showed less sex disparity and was highest in low-middle SDI regions. Major regional risk factors included smoking (East Asia), alcohol (Europe), and tobacco chewing (South Asia). Forecasts suggested rising GERD burden and fluctuating EC trends. No global causal link was found between GERD and EC, but region- and sex-specific associations were observed, notably in Central Sub-Saharan Africa and among Australasian females.
CONCLUSION
Despite declining trends of EC burden, geographical and demographic disparities persist. Rising GERD prevalence may affect future EC risk in some populations.…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.